R237 and H238 Are Key Amino Acids in the Rubella Virus E1 Neutralization Epitope

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Viral immunology

• Publication date

  2014-10-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1089/vim.2014.0021PMID 25226223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transmission-Blocking Antibodies against Mosquito C-Type Lectins for Dengue Prevention

  2014cited by this paper
• Complement-Related Proteins Control the Flavivirus Infection of Aedes aegypti by Inducing Antimicrobial Peptides

  2014cited by this paper
• Functional and evolutionary insight from the crystal structure of rubella virus protein E1

  2013cited by this paper
• High throughput solution-based measurement of antibody-antigen affinity and epitope binning

  2013cited by this paper
• Label-free epitope binning assays of monoclonal antibodies enable the identification of antigen heterogeneity.

  2012cited by this paper
• Chaperone Activity of α B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis

  2011cited by this paper
• A C-type lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus infection of mosquitoes.

  2010cited by this paper
• Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles–mumps–rubella–varicella vaccine to children aged 11–21 months

  2010cited by this paper
• Antenatal diagnostic problem of congenital rubella

  2010cited by this paper
• Congenital rubella syndrome: pattern and presentation in a southern Nigerian tertiary hospital

  2009cited by this paper
• Encephalitis in a Child during Atypical Course of Rubella

  2009cited by this paper
• Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.

  2008cited by this paper
• Factors affecting the antigen-antibody reaction.

  2007cited by this paper
• Rubella virus and birth defects: molecular insights into the viral teratogenesis at the cellular level.

  2004cited by this paper
• A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate.

  2004cited by this paper
• A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity.

  2004cited by this paper
• An Outbreak of Rubella aboard a Ship of the German Navy

  2003cited by this paper
• [Immune status of BALB/c mice and rubella virus JR23 strain infection of central nervous system].

  2002cited by this paper
• Role of Arginine 129 in Heparin Binding and Activation of Antithrombin*

  2000cited by this paper
• Rubella virus nonstructural protein 2 is a minor immunogen.

  2000cited by this paper
• Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase.

  2000cited by this paper
• Identification of rubella virus T-cell epitopes recognized in anamnestic response to RA27/3 vaccine: associations with boost in neutralizing antibody titer.

  1999cited by this paper
• Protein identification and analysis tools in the ExPASy server.

  1999cited by this paper
• Ezrin/Radixin/Moesin (ERM) Proteins Bind to a Positively Charged Amino Acid Cluster in the Juxta-Membrane Cytoplasmic Domain of CD44, CD43, and ICAM-2

  1998cited by this paper
• Teratogen update: congenital rubella.

  1998cited by this paper
• Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals

  1996cited by this paper
• Evaluation of rubella virus E2 and C proteins in protection against rubella virus in a mouse model.

  1995cited by this paper
• Expression and characterization of a soluble rubella virus E1 envelope protein

  1994cited by this paper
• An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain

  1993cited by this paper
• Human T- and B-cell epitopes of E1 glycoprotein of rubella virus

  1993cited by this paper
• Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C

  1992cited by this paper
• Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay

  1992cited by this paper
• Antibody response to individual rubella virus proteins in congenital and other rubella virus infections

  1985cited by this paper
• Rubella virus 40S genome RNA specifies a 24S subgenomic mRNA that codes for a precursor to structural proteins

  1984cited by this paper
• Protective Immune Response in BALB/c Mice Induced by the E 72-296 Protein of Rubella Virus

  year unknowncited by this paper

• [Design of a chimeric antigen containing multiple immunodominant epitopes and its use in detection of IgM antibodies against Rubella virus].

  2019cites this paper
• Study of rubella candidate vaccine based on a structurally modified plant virus

  2017cites this paper
• The key role of rubella virus glycoproteins in the formation of immune response, and perspectives on their use in the development of new recombinant vaccines.

  2016cites this paper